Organigram (TSE:OGI – Get Rating) had its price target reduced by research analysts at ATB Capital from C$2.50 to C$2.25 in a report released on Thursday, BayStreet.CA reports. ATB Capital’s price target indicates a potential upside of 181.25% from the stock’s current price. Several other equities analysts also recently weighed in on the company. Stifel […]